Lung Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Lung Cancer

published 1 month ago by Dr Neil Love

Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Dr D Ross Camidge, Dr Stephen V Liu, Prof Solange Peters, Dr Gregory J Riely and Dr David R Spigel. Introduction (00:00) Optimal Therapeutic Approaches for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations — Dr Riely (3:24) Management of NSCLC with ALK Rearrangements or Other Targetable Abnormalities — Dr Camidge (30:37) Current and Emerging Paradigms in the Treatment of Small Cell Lung Cancer (SCLC) — Dr Liu (56:45) Integration of Immune Checkpoint Inhibition into the Management of Locally Advanced NSCLC — Dr Spigel (1:10:55) Available Data with and Current Clinical Role of Anti-PD-1/PD-L1 Antibodies Alone or in Combination with Other Systemic Therapies for Patients with Metastatic NSCLC — Prof Peters (1:34:06) Select publications  

more episodes from Research To Practice | Oncology Videos